High-dose immunosuppressive therapy in generalised myasthenia gravis - A 2-year follow-up study

South African Medical Journal

Volumn 91, Issue 9, 2001, Pages 765-770

  Heckmann, J M ^a   LeePan, E B ^a   Eastman, R W ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHOLINESTERASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG MEGADOSE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; MORBIDITY; MYASTHENIA GRAVIS; PLASMAPHERESIS; REMISSION; SCORING SYSTEM; SIDE EFFECT;

ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYASTHENIA GRAVIS; PREDNISONE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0034792173     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Diseases of the neuromuscular junction
2. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: Result in 153 validated cases and 2 967 diagnostic assays
3. Neuro-muscular junction in myasthenia gravis: Decreased acetylcholine receptors
4. Immune complexes [IgG and C3] at the motor end-plate in myasthenia gravis: Ultrastructural and light microscopic localisation and electrophysiologic correlations
5. Effect of myasthenia immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions
6. Serum factor blocks neuromuscular transmission in Myasthenia Gravis: Electrophysiologic study with intracellular micro-electrodes
7. Plasma exchange in Myastenia Gravis
8. Myasthenia gravis and related syndromes
9. Locating susceptibility genes in myasthenia gravis: A trans-racial approach
10. Clinical, pathological, HLA antigen and immunological evidence for disease heterogenicity in myasthenia gravis
11. IgG from 'seronegative' myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor
12. The natural course of myasthenia gravis and effects of therapeutic measures
13. Effect of immunosuppresive drugs (Azathioprine)
14. Effects of longterm azathioprine alone and combined with steroids in the course of myasthenia gravis
15. Myasthenia Gravis: Clinical Neurology and Neurosurgery Monographs
16. A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis
17. Preliminary results of a double-blind, randomised, placebo-controlled trial of cyclosporine in myasthenia gravis
18. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis
19. Myasthenia Gravis
20. Not so benign long-term immunosuppression in multiple sclerosis?
21. Azathioprine toxicity during long-term immunosuppression of generalised Myasthenia Gravis
22. Long-term neoplasia risk after Azathioprine treatment in inflammatory bowel disease
23. Risk of cancer from Azathioprine therapy in multiple sclerosis: A case-control study
24. The natural course of myasthenia gravis: A long term follow up study